List of Contents

Biomarkers Market Size, Share, and Trends 2024 to 2034

The global biomarkers market size is calculated at USD 94.24 billion in 2025 and is forecasted to reach around USD 318.76 billion by 2034, accelerating at a CAGR of 14.50% from 2025 to 2034. The North America biomarkers market size surpassed USD 37.86 billion in 2024 and is expanding at a CAGR of 14.60% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1182
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Biomarkers Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Biomarkers Market

5.1. Covid-19: Biomarkers Industry Impact
5.2. Biomarkers Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Biomarkers Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Biomarkers Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Rising incidences of cancer
6.1.1.2. Increasing focus on establishment of biomarker-based diagnostic methods
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rapidly expanding applications of biomarkers in diagnostics
6.1.3.2. Technological advancements

Chapter 7. Global Biomarkers Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Biomarkers Market Revenue by Market Players (2019 -2020)
7.1.1.2. Biomarkers Market Revenue Market Share by Market Players (2019 -2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Biomarkers Market, By Type

8.1. Biomarkers Market, by Type, 2022-2034
8.1.1. Validation
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Efficacy
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Safety
8.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Biomarkers Market, By Disease

9.1. Biomarkers Market, by Disease, 2022-2034
9.1.1. Neurological Diseases
9.1.1.1. Market Revenue and Forecast (2022-2034)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2022-2034)
9.1.3. Immunological Diseases
9.1.3.1. Market Revenue and Forecast (2022-2034)
9.1.4. Cardiovascular Diseases
9.1.4.1. Market Revenue and Forecast (2022-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Biomarkers Market, By Application

10.1. Biomarkers Market, by Application, 2022-2034
10.1.1. Personalized Medicines
10.1.1.1. Market Revenue and Forecast (2022-2034)
10.1.2. Drug Discovery & Development
10.1.2.1. Market Revenue and Forecast (2022-2034)
10.1.3. Diagnostics
10.1.3.1. Market Revenue and Forecast (2022-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2022-2034)

Chapter 11. Global Biomarkers Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Type(2022-2034)
11.1.2. Market Revenue Forecast by Disease (2022-2034)
11.1.3. Market Revenue Forecast by Application (2022-2034)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2022-2034)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2022-2034)
11.2. Europe
11.2.1. Market Revenue Forecast by Type (2022-2034)
11.2.2. Market Revenue Forecast by Disease (2022-2034)
11.2.3. Market Revenue Forecast by Application (2022-2034)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2022-2034)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2022-2034)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2022-2034)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2022-2034)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Type (2022-2034)
11.3.2. Market Revenue Forecast by Disease (2022-2034)
11.3.3. Market Revenue Forecast by Application (2022-2034)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2022-2034)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2022-2034)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2022-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2022-2034)
11.4. LATAM
11.4.1. Market Revenue Forecast by Type (2022-2034)
11.4.2. Market Revenue Forecast by Disease (2022-2034)
11.4.3. Market Revenue Forecast by Application (2022-2034)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2022-2034)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2022-2034)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Type (2022-2034)
11.5.2. Market Revenue Forecast by Disease (2022-2034)
11.5.3. Market Revenue Forecast by Application (2022-2034)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2022-2034)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2022-2034)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2022-2034)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2022-2034)

Chapter 12. Company Profiles

12.1. Bio-Rad Laboratories, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Disease
12.1.3. Revenue, Price, and Gross Margin (2022-2034)
12.1.4. Recent Developments and Strategies
12.2. Qiagen
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Disease
12.2.3. Revenue, Price, and Gross Margin (2022-2034)
12.2.4. Recent Developments and Strategies
12.3. Epigenomics AG
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Disease
12.3.3. Revenue, Price, and Gross Margin (2022-2034)
12.3.4. Recent Developments and Strategies
12.4. Abbott
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Disease
12.4.3. Revenue, Price, and Gross Margin (2022-2034)
12.4.4. Recent Developments and Strategies
12.5. F. Hoffmann-La Roche Ltd.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Disease
12.5.3. Revenue, Price, and Gross Margin (2022-2034)
12.5.4. Recent Developments and Strategies
12.6. Agilent Technologies, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Disease
12.6.3. Revenue, Price, and Gross Margin (2022-2034)
12.6.4. Recent Developments and Strategies
12.7. Johnson & Johnson Services, Inc.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Disease
12.7.3. Revenue, Price, and Gross Margin (2022-2034)
12.7.4. Recent Developments and Strategies
12.8. Abbott
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Disease
12.8.3. Revenue, Price, and Gross Margin (2022-2034)
12.8.4. Recent Developments and Strategies
12.9. Siemens
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Disease
12.9.3. Revenue, Price, and Gross Margin (2022-2034)
12.9.4. Recent Developments and Strategies
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Disease
12.10.3. Revenue, Price, and Gross Margin (2022-2034)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biomarkers market size was estimated at USD 82.30 billion in 2024 and is predicted to reach USD 318.76 billion by the end of 2034.

The global biomarkers market is growing at a CAGR of 14.50% from 2025 to 2034.

Biomarker (portmanteau of biological marker) is the attribute that is accurately measured and assessed as an indicator of regular biological processes, pathogenic procedures or pharmacological reaction to a therapeutic interference.

Factors such as high incidence of cancer, increasing focus on establishment of biomarker-based diagnostic methods, and growing number of contract research organizationsare driving the growth of biomarkers market.

In 2024, North America dominated the global market with a market share of more than 46%.

Safety Biomarkers segment recorded the prime market share in the global biomarkers market by type in 2024.

The use of biomarkers is on a constant rise in drug discovery and development majorly due to the advantages offered by biomarkers to scaleup the clinical development stage. These factors contribute to the growth of drug discovery & development segment.

The major companies functioning in the worldwide biomarkers market are Bio-Rad Laboratories, Inc., Epigenomics AG, Qiagen, Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Abbott, Siemens, and Thermo Fisher Scientific, Inc. among others.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us